Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 10 | 2022 | 60 | 3.600 |
Why?
|
| Caspases | 8 | 2022 | 146 | 2.380 |
Why?
|
| Phytol | 3 | 2011 | 3 | 1.240 |
Why?
|
| Adjuvants, Immunologic | 3 | 2011 | 61 | 1.200 |
Why?
|
| Caspase 1 | 5 | 2022 | 28 | 1.180 |
Why?
|
| Caspases, Initiator | 5 | 2020 | 9 | 1.170 |
Why?
|
| Cytosol | 3 | 2020 | 101 | 1.160 |
Why?
|
| Immunity, Innate | 5 | 2020 | 114 | 1.120 |
Why?
|
| Burkholderia | 4 | 2020 | 16 | 1.030 |
Why?
|
| Neutrophils | 3 | 2022 | 154 | 0.930 |
Why?
|
| Toxins, Biological | 1 | 2022 | 7 | 0.890 |
Why?
|
| Cell Death | 3 | 2015 | 223 | 0.880 |
Why?
|
| Lipopolysaccharides | 2 | 2020 | 200 | 0.810 |
Why?
|
| Interleukin-18 | 3 | 2020 | 27 | 0.760 |
Why?
|
| Pneumonia, Bacterial | 1 | 2020 | 26 | 0.750 |
Why?
|
| Vaccines | 2 | 2011 | 65 | 0.750 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 37 | 0.750 |
Why?
|
| Interferon-gamma | 3 | 2020 | 195 | 0.720 |
Why?
|
| Cytokines | 6 | 2013 | 677 | 0.660 |
Why?
|
| Mice | 13 | 2022 | 6428 | 0.600 |
Why?
|
| Lung | 1 | 2020 | 508 | 0.580 |
Why?
|
| Neuronal Apoptosis-Inhibitory Protein | 1 | 2016 | 1 | 0.570 |
Why?
|
| Alum Compounds | 2 | 2011 | 6 | 0.520 |
Why?
|
| Macrophages | 2 | 2020 | 404 | 0.510 |
Why?
|
| Animals | 15 | 2022 | 14409 | 0.500 |
Why?
|
| Chemokines | 2 | 2011 | 96 | 0.490 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2013 | 43 | 0.470 |
Why?
|
| Intestinal Mucosa | 2 | 2012 | 259 | 0.460 |
Why?
|
| Vacuoles | 1 | 2013 | 27 | 0.450 |
Why?
|
| Communicable Diseases | 1 | 2013 | 58 | 0.430 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2011 | 3 | 0.420 |
Why?
|
| Phosphate-Binding Proteins | 2 | 2022 | 7 | 0.420 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 111 | 0.390 |
Why?
|
| Calcium-Binding Proteins | 4 | 2020 | 61 | 0.390 |
Why?
|
| Autoantibodies | 1 | 2011 | 135 | 0.390 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 151 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 2001 | 0.380 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 115 | 0.380 |
Why?
|
| Burkholderia Infections | 2 | 2020 | 6 | 0.310 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 370 | 0.280 |
Why?
|
| Signal Transduction | 3 | 2020 | 1752 | 0.260 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2020 | 96 | 0.240 |
Why?
|
| Cellular Microenvironment | 2 | 2012 | 27 | 0.210 |
Why?
|
| Phthalic Acids | 2 | 2011 | 2 | 0.210 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2011 | 8 | 0.210 |
Why?
|
| Immunity, Humoral | 2 | 2011 | 25 | 0.200 |
Why?
|
| Brefeldin A | 1 | 2020 | 19 | 0.200 |
Why?
|
| Intestine, Small | 2 | 2012 | 123 | 0.200 |
Why?
|
| Bacteria | 1 | 2022 | 258 | 0.190 |
Why?
|
| Swine | 2 | 2011 | 430 | 0.190 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 92 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 143 | 0.170 |
Why?
|
| Flow Cytometry | 1 | 2020 | 547 | 0.160 |
Why?
|
| Th2 Cells | 2 | 2012 | 26 | 0.130 |
Why?
|
| Th1 Cells | 2 | 2012 | 50 | 0.130 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 106 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2015 | 105 | 0.130 |
Why?
|
| Lipid A | 1 | 2013 | 9 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 658 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 51 | 0.110 |
Why?
|
| Burkholderia pseudomallei | 1 | 2013 | 9 | 0.110 |
Why?
|
| Salmonella Infections, Animal | 1 | 2013 | 17 | 0.110 |
Why?
|
| Phagosomes | 1 | 2013 | 21 | 0.110 |
Why?
|
| Salmonella typhimurium | 1 | 2013 | 54 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2013 | 80 | 0.110 |
Why?
|
| Mice, Inbred NZB | 1 | 2011 | 2 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2011 | 56 | 0.100 |
Why?
|
| Ovalbumin | 1 | 2011 | 17 | 0.100 |
Why?
|
| Haptens | 1 | 2011 | 14 | 0.100 |
Why?
|
| Ascitic Fluid | 1 | 2011 | 13 | 0.100 |
Why?
|
| Protein Array Analysis | 1 | 2011 | 28 | 0.100 |
Why?
|
| Emulsions | 1 | 2011 | 27 | 0.100 |
Why?
|
| Diterpenes | 1 | 2011 | 32 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 46 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 134 | 0.100 |
Why?
|
| Models, Animal | 1 | 2011 | 255 | 0.100 |
Why?
|
| Necrosis | 1 | 2011 | 208 | 0.100 |
Why?
|
| Female | 4 | 2020 | 28471 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 227 | 0.100 |
Why?
|
| Humans | 5 | 2020 | 54391 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 674 | 0.090 |
Why?
|
| Vaccination | 1 | 2011 | 298 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2011 | 360 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 363 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 570 | 0.080 |
Why?
|
| DNA | 1 | 2011 | 581 | 0.080 |
Why?
|
| Inflammation | 1 | 2011 | 678 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1141 | 0.070 |
Why?
|
| Apoptosis | 1 | 2011 | 1302 | 0.060 |
Why?
|
| Male | 1 | 2020 | 27347 | 0.040 |
Why?
|
| Chromobacterium | 1 | 2015 | 1 | 0.030 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2015 | 3 | 0.030 |
Why?
|
| Listeriosis | 1 | 2015 | 7 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2015 | 11 | 0.030 |
Why?
|
| Spleen | 1 | 2015 | 187 | 0.030 |
Why?
|
| Francisella | 1 | 2013 | 1 | 0.030 |
Why?
|
| Cross-Priming | 1 | 2013 | 1 | 0.030 |
Why?
|
| Poly I-C | 1 | 2013 | 3 | 0.030 |
Why?
|
| Salmonella Infections | 1 | 2013 | 15 | 0.030 |
Why?
|
| Salmonella | 1 | 2013 | 25 | 0.030 |
Why?
|
| CD30 Ligand | 1 | 2012 | 1 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 2012 | 9 | 0.030 |
Why?
|
| Chemokine CX3CL1 | 1 | 2012 | 9 | 0.030 |
Why?
|
| Guided Tissue Regeneration | 1 | 2012 | 4 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 328 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 128 | 0.030 |
Why?
|
| Wound Healing | 1 | 2012 | 228 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1226 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 825 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1063 | 0.020 |
Why?
|